PharmiWeb.com - Global Pharma News & Resources
04-Feb-2021

Blood Stream Infection Testing Market Size Enlarging Global Business with Highest Revenue US$ 7,728.4 Million by 2026 | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Global Blood Stream Infection Testing Marketby Product Type (Instruments, Reagents, and Others), by Technology (Conventional Testing and Non-conventional Testing), by Test Type (Conventional Blood Culture Tests, PCR Method, Nucleic Acid Testing, Mass Spectroscopy, and Point-of-Care Testing), by End User (Hospitals, Independent Diagnostics Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 3,758.7 million in 2017, and is estimated to exhibit a CAGR of 8.4% over the forecast period (2019-2026), as highlighted in a new report published by Coherent Market Insights. 

Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/1727

The increasing prevalence of abdominal infection, dental infection, kidney and urinary infection, chronic diseases, coupled with rising geriatric population are the factors that are expected to drive the market growth over the forecast period. For instance, according to the Global Burden of Disease Study 2016 estimation, around 3.58 million people, across the globe suffered from dental caries, and it is estimated that 2.4 billion people suffer from carries of permanent teeth, globally.

Moreover, high incidence of burns/wounds cases, HIV, pneumonia, pyelonephritis, and cancer, coupled with growing awareness about hygiene are the factors that are further expected to boost the global blood stream infection testing market growth. For instance, according to the World Health Organization, at the end of 2017, around 36.9 million people were living with HIV and 1.8 million people reported to be newly infected in 2017 globally. Furthermore, advancements in diagnostic testing is expected to fuel the market growth over the forecast period. For instance, researchers from the University of Illinois and Charle Foundation Hospital completed a clinical study of a device that can detect sepsis from a single drop of blood, in 2017. Similarly, in April 2017, BioMérieux, a major player in the field of in vitro diagnostics, announced about its BacT/ALERT VIRTUO, a fully automated blood culture system, to receive 510(k) clearance from the U.S. Food and Drug Administration (FDA). This innovative blood culture microbial detection system enhances the blood culture performance for rapid detection, thereby offering faster identification of bloodstream infection.

Browse 22 Market Data Tables and 20 Figures spread through 178 Pages and in-depth TOC on “Blood Stream Infection Testing Market”- Global Forecast to 2026, by Product Type (Instruments, Reagents, and Others), By Technology (Conventional Testing and Non-conventional Testing), by Test Type (Conventional Blood Culture Tests, PCR Method, Nucleic Acid Testing, Mass Spectroscopy, and Point-of-Care Testing), By End User (Hospitals, Independent Diagnostics Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in the bloodstream infection testing market press release, click the link below: https://www.coherentmarketinsights.com/press-release/blood-stream-infection-testing-market-to-surpass-us-77284-million-by-2026-1687

Major market players in the market are focusing on launching new tests for detection of various infectious diseases. For instance, Becton, Dickson and Company launched molecular test to detect the tuberculosis and multidrug-resistant tuberculosis, in October 2018.

Key Takeaways of the Blood Stream Infection Testing Market:

  • The global blood stream infection testing market is expected to exhibit a CAGR of 8.4% over the forecast period, attributed to high prevalence of abdominal infections, dental infections, and chronic diseases
  • Among product type, instruments segment held a dominant position in the blood stream infection testing market in 2018, attributed to various new innovations by key players for synthesizing bloodstream infection tests to detect the infectious diseases
  • Key players operating in the global blood stream infection testing market include bioMérieux SA, Becton, Dickinson and Company, AB Sciex, IRIDICA, Abbot Laboratories, Cepheid Inc., C. R. Bard, Inc., F. Hoffmann-La Roche AG, Nanoshpere, Dade Behring, AdvanDX, and Siemens Healthcare

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1727

Detailed Segmentation:

  • Global Blood Stream Infection Testing Market, By Product Type:
    • Instruments
    • Reagents
    • Others
  • Global Blood Stream Infection Testing Market, By Technology:
    • Conventional Testing
    • Non-conventional Testing
  • Global Blood Stream Infection Testing Market, By Test Type:
    • Conventional Blood Culture Tests
    • PCR Method
    • Nucleic Acid Testing
    • Mass Spectroscopy
    • Point-of-Care Testing
  • Global Blood Stream Infection Testing Market, By End User:
    • Hospitals
    • Independent Diagnostics Centers
    • Others
  • Global Blood Stream Infection Testing Market, By Region:
    • North America
      • By Product Type:
        • Instruments
        • Reagents
        • Others
      • By Technology:
        • Conventional Testing
        • Non-conventional Testing
      • By Test Type:
        • Conventional Blood Culture Tests
        • PCR Method
        • Nucleic Acid Testing
        • Mass Spectroscopy
        • Point-of-Care Testing
      • By End User:
        • Hospitals
        • Independent Diagnostic Centers
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
      • By Technology:
      • By Test Type:
      • By End User:
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
      • By Technology:
      • By Test Type:
      • By End User:
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
      • By Technology:
      • By Test Type:
      • By End User:
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
      • By Technology:
      • By Test Type:
      • By End User:
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
      • By Technology:
      • By Test Type:
      • By End User:
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 04-Feb-2021